Adrenomed’s goal is to fill the gap in patient treatment further downstream of inflammation with Adrecizumab, the first sepsis therapy candidate to target an important causal pathophysiology of ...
Sepsis, a life-threatening organ dysfunction, is responsible for an estimated 1 in 5 deaths globally and 1 in 3 deaths that ...
Despite similar clinical presentations, the molecular and cellular processes that elicit the sepsis response differ depending on whether the organism is gram-negative, gram-positive, fungal ...
The Harvard Pilgrim Health Care Institute is proud to announce the launch of the Center for Sepsis Epidemiology and ...
It's a copycat killer—often mimicking less severe conditions and delaying much-needed, timely treatments. But sepsis—an ...
Sepsis is an underestimated killer. Nearly a quarter of patients treated for sepsis in hospital will die, but because so many ...
Like a poison pen, dying cells prick their neighbors with a lethal message. This may worsen sepsis, Vijay Rathinam and colleagues in the UConn School of Medicine report in the Jan. 23 issue of Cell.
One night he was looking after a baby boy who had sepsis, which is where the immune ... It feels like we're discovering ...
It's a copycat killer - often mimicking less severe conditions and delaying much-needed, timely treatments. But sepsis - an infection that can lead to ...
The American College of Chest Physicians and the Society of Critical Care Medicine (ACCP/SCCM) developed consensus definitions for sepsis in 1992. [6] There has been much discussion about the ...